RETATRUTIDE

What is RETATRUTIDE?

Retatrutide is a novel investigational peptide that acts as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is currently being researched for its potential applications in metabolic and weight-management studies within laboratory settings.

Key Features

• Lyophilized peptide supplied in sterile vial
• ≥99% purity (third-party verified)
• Free from fillers or unnecessary additives
• Manufactured in ISO-certified facility
• Independently tested for identity and quality assurance

Recommended Use

For research purposes only. Not for human or veterinary consumption. Intended strictly for laboratory and analytical research applications.

Third-Party Testing

All Zyros Labs batches undergo independent laboratory analysis to verify purity, identity, and overall quality standards. Certificates of Analysis are available upon request.

Storage & Handling

• Store lyophilized vial at ≤25°C
• Keep away from direct sunlight, moisture, and heat
• Reconstitute using suitable laboratory-grade bacteriostatic water
• Handle using sterile laboratory procedures and appropriate PPE

Legal Disclaimer

This product is sold strictly for laboratory research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Zyros Labs does not promote or endorse human use.